- Genmab (NJ)
- …innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting ... in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab's vision is to transform the lives of people with cancer and other… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …developing advanced cell therapies across a diverse array of technology platforms , including autologous and allogenic chimeric antigen receptor T-cell, T-cell ... receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …developing advanced cell therapies across a diverse array of technology platforms , including autologous and allogenic chimeric antigen receptor T-cell, T-cell ... receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend… more
- Formation Bio (New York, NY)
- …Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms , processes, and capabilities to accelerate all aspects of drug development and ... clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …developing advanced cell therapies across a diverse array of technology platforms , including autologous and allogenic chimeric antigen receptor T-cell, T-cell ... receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend… more
- Merck & Co. (Rahway, NJ)
- …external device designers, developers, and suppliers for selected device technology platforms .Oversee and serve as a technical integrator of all device development ... activities including engineering design, engineering analysis and testing, medical device design controls, risk management, test method/fixture development, design verification and validation, injection molding, automated assembly, and human factors… more
- BioAgilytix (Durham, NC)
- …SkillsAbility to develop immunoassays in some or all of the following platforms : ELISA, MSD-ECL, RIA, DELFIA, HTRF, and AlphaScreenExperience in AAV/gene therapy ... (preferred)Work effectively within team to meet objectives under time constraintsAbility to perform under stress and multi-taskDetail oriented and highly organizedExcellent oral and written communication skillsProficient in the use of MS Excel and… more
- Merck & Co. (South San Francisco, CA)
- …of the strategic plan within CMD, including integration of new technology platforms , human biology, data science, while focusing on uncovering novel biology that ... delivers high-quality drug discovery pipeline.-We are a research-driven biopharmaceutical company. -Our mission is built on the simple premise that if we "follow the science" and that great medicines can make a significant impact to our world.- We believe that… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …developing advanced cell therapies across a diverse array of technology platforms , including autologous and allogenic chimeric antigen receptor T-cell, T-cell ... receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.Legend… more
- Los Angeles Times (El Segundo, CA)
- …We push the boundaries of traditional media, exploring new formats and platforms to reach diverse and global audiences. By championing innovative ideas and ... reflect the brand's tone and messaging. Adapt designs for different platforms and formats, optimizing for accessibility, visibility, and user engagement. Design… more
